Valuation: Stem Cells Spin S.A.

Market Cap	15.46M 4.07M 3.57M 3.31M 3.04M 5.76M 390M 5.87M 39.42M 191M 15.29M 14.95M 661M	P/E 2024	-15.6x	P/E 2025	-31.9x
Enterprise Value	15.54M 4.09M 3.59M 3.33M 3.06M 5.79M 392M 5.9M 39.63M 192M 15.37M 15.04M 664M	EV / Sales 2024	151x	EV / Sales 2025	257x
Free-Float	19.04%	Yield 2024 *	-	Yield 2025	-

* Estimated data More valuation ratios

Latest news : Stem Cells Spin S.A.

05-15	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-16	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
11-14	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
13/05/25	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2025	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Full Year Ended December 31, 2024	CI
14/02/25	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2024	CI
14/08/24	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	CI
15/05/24	Stem Cells Spin S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI
14/02/24	Stem Cells Spin S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	CI
14/11/23	Stem Cells Spin S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
14/08/23	Stem Cells Spin S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

More news

Managers and Directors: Stem Cells Spin S.A.

Manager	Title	Age	Since
Adam Symber CEO	Chief Executive Officer	45	01/01/2017

Director	Title	Age	Since
Marek Andrzej Cegielski BRD	Director/Board Member	74	28/06/2022
Andrzej Jan Trznadel BRD	Director/Board Member	64	-
Piotr Okoniewski BRD	Director/Board Member	-	15/03/2022

More insiders

Other Biotechnology & Medical Research

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STEM CELLS SPIN S.A.	-6.50%	-6.50%	+30.77%	-6.50%	4.08M
LONZA GROUP AG	+0.44%	+2.51%	+4.36%	+10.27%	50.73B
REVOLUTION MEDICINES, INC.	-1.57%	-3.18%	+379.41%	+593.37%	39.73B
IQVIA HOLDINGS INC.	-0.14%	+0.77%	+29.61%	-5.50%	34.69B
BEONE MEDICINES AG	+1.76%	-1.78%	+20.55%	+53.38%	33.21B
CELLTRION, INC.	-0.06%	-4.63%	+2.94%	+31.65%	26.76B
ASCENDIS PHARMA A/S	-1.93%	-1.01%	-	-	16.8B
MEDPACE HOLDINGS, INC.	-1.49%	-6.18%	+65.50%	+120.53%	15.37B
EUROFINS SCIENTIFIC SE	+0.78%	+0.20%	+14.69%	+17.08%	13.78B
ICON PUBLIC LIMITED COMPANY	-0.97%	-2.83%	+11.09%	-33.29%	12.85B
Average	-1.00%	-1.53%	+62.10%	+86.78%	24.39B
Weighted average by Cap.	-0.24%	-0.38%	+81.17%	+124.10%

See all sector performances

Stem Cells Spin SA is a Poland-based company. It is primarily engaged in biotechnology research. The Company is focused on development, production, marketing and sale of natural regenerative products for the dermocosmetic and veterinary care markets.

Employees

Sector

Biotechnology & Medical Research

Calendar

08-14 - Earnings release - Q2 2026

More about the company

Quotes

Date	Price	Change	Volume
10/07/26	PLN 0.3740	-6.50%	1,453
08/07/26	PLN 0.4000	-0.50%	100
07/07/26	PLN 0.4020	+0.50%	5,027

End-of-day quote Warsaw S.E.

More quotes

Income Statement and Estimates

More financial data

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

United-States

Canada

End-of-day quote Warsaw S.E. Other stock markets 10/07/2026			5-day change	1st Jan Change
0.3740 ^PLN	-6.50%		-6.50%	-7.88%

1 day	-6.50%
1 week	-6.50%
Current month	-6.50%
1 month	-6.50%
3 months	-3.11%
6 months	-7.88%
Current year	-7.88%

1 week	0.37	0.4
1 month	0.37	0.44
Current year	0.33	0.48
1 year	0.26	0.52
3 years	0.14	0.82
5 years	0.14	1.23
10 years	0.14	2.04

	2024	2025
Net sales	54.28K 14.29K 12.54K 11.61K 10.68K 20.21K 1.37M 20.6K 138K 672K 53.68K 52.5K 2.32M	65.74K 17.31K 15.18K 14.06K 12.94K 24.47K 1.66M 24.95K 168K 814K 65K 63.58K 2.81M
Net income	-520K -137K -120K -111K -102K -194K -13.11M -197K -1.33M -6.44M -514K -503K -22.24M	-526K -138K -121K -112K -103K -196K -13.25M -200K -1.34M -6.51M -520K -508K -22.47M
Net Debt	69.28K 18.24K 16K 14.82K 13.64K 25.79K 1.75M 26.3K 177K 858K 68.51K 67.01K 2.96M	84.58K 22.27K 19.54K 18.09K 16.65K 31.49K 2.13M 32.1K 216K 1.05M 83.64K 81.81K 3.62M

Stem Cells Spin S.A. Stock

Stocks

SCS

PLSTCLS00013

Biotechnology & Medical Research

Valuation: Stem Cells Spin S.A.

Chart: Stem Cells Spin S.A.

Latest news : Stem Cells Spin S.A.

Quotes and Performance

Course Extremes

Managers and Directors: Stem Cells Spin S.A.

Other Biotechnology & Medical Research

Financials

Company Profile

Quotes

Income Statement and Estimates